Your browser doesn't support javascript.
loading
Advance of study on demethylation in leukemia - review / 中国实验血液学杂志
Journal of Experimental Hematology ; (6): 1247-1250, 2008.
Article in Chinese | WPRIM | ID: wpr-234257
ABSTRACT
DNA methylation is a frequent change in epigenetics of leukemia. In the development of leukemia, methylation plays an important role in the genetic expression regulation and genetic structure stabilization. Hematopoietic stem cell transplantation (HSCT) and chemotherapy are the common methods to cure leukemia at present. Unfortunately, it is very hard to find suitable donor for transplantation, while the relapse and drug resistance are the unresolved problems in chemotherapy. Because of the reversibility of methylation, the drugs reducing the level of methylation become a new way to cure leukemia. Decitabine is the most common medicament used to reduce the level of methylation. In this article, the methylation and tumor, methylation and hematologic diseases, methylation detection methods, demethylation therapy in leukemia and so on are reviewed.
Subject(s)
Full text: Available Index: WPRIM (Western Pacific) Main subject: Leukemia / DNA Methylation Limits: Humans Language: Chinese Journal: Journal of Experimental Hematology Year: 2008 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Leukemia / DNA Methylation Limits: Humans Language: Chinese Journal: Journal of Experimental Hematology Year: 2008 Type: Article